Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA PCBP1-AS1-mediated AR/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance
Boya Zhang, Mingpeng Zhang, Chunyi Shen, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 51
Targeting PI3K/Akt signaling in prostate cancer therapy
Mehrdad Hashemi, Afshin Taheriazam, Padideh Daneii, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 423-443
Open Access | Times Cited: 45
A comprehensive review on the emerging role of long non-coding RNAs in the regulation of NF-κB signaling in inflammatory lung diseases
Asif Ahmad Bhat, Obaid Afzal, Neetu Agrawal, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126951-126951
Closed Access | Times Cited: 35
Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Long non-coding RNAs in drug resistance across the top five cancers: Update on their roles and mechanisms
Yue Shi, Joseph Adu‐Amankwaah, Qizhong Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27207-e27207
Open Access | Times Cited: 8
The Crucial Role of AR-V7 in Enzalutamide-Resistance of Castration-Resistant Prostate Cancer
Zeyuan Zheng, Jinxin Li, Yankuo Liu, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4877-4877
Open Access | Times Cited: 37
Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma
Shijie Mai, Liping Liang, Genghui Mai, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
Non-coding RNAs in enzalutamide resistance of castration-resistant prostate cancer
Ke Gao, Xiaoshun Li, Jianxin Ni, et al.
Cancer Letters (2023) Vol. 566, pp. 216247-216247
Closed Access | Times Cited: 16
Androgen‐repressed lncRNA LINC01126 drives castration‐resistant prostate cancer by regulating the switch between O‐GlcNAcylation and phosphorylation of androgen receptor
Yi Cai, Minfeng Chen, Yuchen Gong, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Exploring the enigma: history, present, and future of long non-coding RNAs in cancer
Qais Ahmad Naseer, Abdul Malik, Fengyuan Zhang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer
Lin Chen, Yuxin Xu, Yuanshuo Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 331, pp. 118265-118265
Closed Access | Times Cited: 4
Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways
Ahmed S. Doghish, Sherif S. Abdel Mageed, Mohamed Bakr Zaki, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis
Zengshu Xing, Sailian Li, Jiansheng Xing, et al.
Laboratory Investigation (2022) Vol. 102, Iss. 6, pp. 602-612
Open Access | Times Cited: 16
Reciprocal regulation between RACGAP1 and AR contributes to endocrine therapy resistance in prostate cancer
Jia-Jia Wang, Hui Liu, Zeyuan Yu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers
Eva Chrenková, Hana Študentová, Kateřina Holá, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Advances in the Current Understanding of the Mechanisms Governing the Acquisition of Castration-Resistant Prostate Cancer
Yifeng Mao, Gaowei Yang, Yingbang Li, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3744-3744
Open Access | Times Cited: 15
LncRNA PCBP1-AS1 induces osteoporosis by sponging miR-126-5p/PAK2 axis
Z Li
Bone and Joint Research (2023) Vol. 12, Iss. 6, pp. 375-386
Open Access | Times Cited: 7
The kinesin-14 family motor protein KIFC2 promotes prostate cancer progression by regulating p65
Xin Yu Liu, Yu Lin, Weibing Long, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 11, pp. 105253-105253
Open Access | Times Cited: 7
Role of non-coding RNA in lineage plasticity of prostate cancer
Wenhui Tan, Changkai Xiao, Min Ma, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 2
circPHF16 suppresses prostate cancer metastasis via modulating miR-581/RNF128/Wnt/β-catenin pathway
Lifeng Ding, Yudong Lin, Xianjiong Chen, et al.
Cellular Signalling (2022) Vol. 102, pp. 110557-110557
Open Access | Times Cited: 12
Contribution of the Testosterone Androgen Receptor–PARD3B Signaling Axis to Tumorigenesis and Malignance of Glioblastoma Multiforme through Stimulating Cell Proliferation and Colony Formation
Jr-Di Yang, Jui‐Tai Chen, Shing‐Hwa Liu, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4818-4818
Open Access | Times Cited: 9
A thorough understanding of the role of lncRNA in prostate cancer pathogenesis; Current knowledge and future research directions
Ramin Haghighi, Roxana Yolanda Castillo-Acobo, Ali H. Amin, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154666-154666
Closed Access | Times Cited: 5
SWI/SNF chromatin remodelers in prostate cancer progression
Sandra C. Ordonez-Rubiano, Brayden P. Strohmier, Surbhi Sood, et al.
Frontiers in Epigenetics and Epigenomics (2024) Vol. 1
Open Access | Times Cited: 1
Decoding long non‑coding RNAs: Friends and foes in cancer development (Review)
Hequn Song, Joseph Adu‐Amankwaah, Qizhong Zhao, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 6
Open Access | Times Cited: 1
The role of protein post-translational modifications in prostate cancer
Yinghui Hao, Chenqiong Gu, Wenfeng Luo, et al.
PeerJ (2024) Vol. 12, pp. e17768-e17768
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top